A Graduate Tenant of the West Virginia University Business Incubator recently released for purchase a new product. Protea Biosciences, Inc. is going public with the GPR-800, which is designed to analyze protein much more precisely and rapidly than previously existing technologies.
The GPR-800 takes about twenty minutes to test, can analyze eight samples at a time, and because it uses disposable chips for each individual test, contamination from previous samples will no longer be an issue. All of this means that the GPR-800 is much more time-efficient and productive than previous similar devices that required perhaps six hours to analyze samples.
Protea’s Director of Marketing, Reid Asbury, told The State Journal that “…proteins themselves actually perform the functions; they can be modified, over expressed or under expressed, and that causes disease. Most drugs are either proteins or substances that can interact with proteins.” This means that the GPR-800 is a useful device to virtually everyone in the medical and pharmaceutical fields as a means of studying protein more quickly and accurately. (Wowktv.com).
“Our new GPR-800 bench top instrument uses an advanced, proprietary, multichannel micro fluidic chip technology, and is an important advance in the proteomics field,” Asbury said in the press release. “Because it allows the biologist to prepare ‘mass spectrometry ready’ protein samples in a fraction of the time, we believe the GPR-800 represents a major breakthrough and productivity advancement for today’s busy proteomics research laboratory.” (Smalltimes.com).
“The GPR-800 instrument system opens up many new exciting applications including top down proteomic experiments and analysis of modification states of proteins. Researchers can quickly determine the accurate intact mass of their gel separated proteins using mass spectrometry.
Protea Biosciences, Inc. was founded to develop and commercialize new technology that improves the recovery, identification and characterization of proteins in biological samples. The company markets new protein research products and services to pharmaceutical, biotechnology and academic research laboratories worldwide.” (GlobeNewsWire.com).
Protea is selling the GPR-800 for $16,900 and currently has many interested customers.
For more information, visit these websites:
www.wowktv.com
www.smalltimes.com
www.globenewswire.com
Posted by Vanessa White on March 6, 2009 at 10:35 am in the following categories: Protea Biosciences
